The report titled “Interventional Oncology Market by Product (Radiofrequency, microwave, cryoablation, embolization, guidewires), Procedures (Thermal Ablation, Non-Thermal Ablation, TACE, TARE, TAE), Cancer (Liver, Lung, Kidney, Bone Metastasis) – Global Forecast to 2024” sheds a concentrated focus on the Interventional Oncology industry in terms of market driver, opportunities, restraints terms of global segmentation. Further data on the reports also includes demographic conditions and analyzing country-to-market.
Need a Free Sample Report? Visit: https://www.reportsnreports.com/contacts/requestsample.aspx?name=2029743
The Global Interventional Oncology Market is projected to reach USD 2.9 Billion by 2024 from USD 2.0 Billion in 2019, at a CAGR of 6.8% from 2019 to 2024.
Top Companies Profiled in the Interventional Oncology Market:
- Medtronic -Ireland
- Boston Scientific -US
- BTG plc -UK
- Merit Medical Systems -US
On the basis of procedure, the interventional oncology market is segmented into thermal tumor ablation, non-thermal tumor ablation, transcatheter arterial chemoembolization TACE, transcatheter arterial radioembolization TARE or selective internal radiation therapy SIRT, and transcatheter arterial embolization TAE or bland embolization procedures.
Based on cancer type, the interventional oncology market is segmented into liver cancer, lung cancer, kidney cancer, bone cancer, and other cancers. The other cancers segment includes pediatric cancer, prostate cancer, and breast cancer. The liver cancer segment accounted for the largest share in the interventional oncology market in 2018.
Access full report with all information @ https://www.reportsnreports.com/purchase.aspx?name=2029743
Table of Contents:
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study